Henry Schein (HSIC) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $10.08B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Distribution |
| Country | US | CEO | Frederick Lowery |
| IPO Date | 1995-11-03 | CAGR | 11.23% |
| Employees | 25,000 | Website | www.henryschein.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 7.2% | Total Yield | 7.2% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $13.22B | P/E | 16.67 | Forward P/E | 14.75 | PEG | 1.51 |
| P/S | 0.73 | P/B | 3.18 | P/CF | 14.39 | P/FCF | 18.76 |
| Sales | $13.60B | Sales 1Y | 6.49% | Sales 3Y | 7.97% | Sales 5Y | 14.32% |
| EPS | $5.31 | EPS 1Y | 10.65% | EPS 3Y | 0.59% | EPS 5Y | -18.91% |
| Sales QoQ | 2.67% | EPS QoQ | -10.87% | Sales QoQ Avg | 1.66% | EPS QoQ Avg | 4.64% |
| Gross Margin | 30.31% | Operating Margin | 5.69% | Profit Margin | 2.96% | ROCE | 9.81% |
| ROA | 4% | ROE | 12% | Altman Z Score | 2.83 | Piotroski Score | 6 |
| Current Ratio | 1.32 | Quick Ratio | 0.73 | Cash Ratio | 0.05 | Op. CF Ratio | 0.07 |
| Debt/Equity | 1.21 | Debt/Assets | 0.34 | Lt Debt/Equity | 0.82 | Lt Debt/Cap. | 0.42 |
| Intrst Cov. | 4.87 | Inventory Turnover | 4.6 | Asset Turnover | 1.2 | Receivables Turnover | 7.72 |
| Enterprise Value | $13.22B | P/E Ratio | 16.67 |
| Forward P/E | 14.75 | PEG Ratio | 1.51 |
| P/S Ratio | 0.73 | P/B Ratio | 3.18 |
| P/CF Ratio | 14.39 | P/FCF Ratio | 18.76 |
| EPS | $5.31 | EPS Growth 1Y | 10.65% |
| EPS Growth 3Y | 0.59% | EPS Growth 5Y | -18.91% |
| Revenue Growth 1Y | 6.49% | Gross Margin | 0.3% |
| Operating Margin | 0.06% | Profit Margin | 0.03% |
| ROE | 0.12% | ROA | 0.04% |
| ROCE | 0.1% | Current Ratio | 1.32 |
| Quick Ratio | 0.73 | Cash Ratio | 0.05 |
| Debt/Equity | 1.21 | Interest Coverage | 4.87 |
| Altman Z Score | 2.83 | Piotroski Score | 6 |
Henry Schein (HSIC) valuation & financials
Henry Schein (HSIC) has a market capitalization of $10.08B and trades at a price-to-earnings ratio of 16.7. It operates in the Healthcare sector (Medical - Distribution).
Henry Schein's revenue grew +6.5% over the last year.
Henry Schein's next earnings report is scheduled for November 3, 2026 before market open; analysts estimate EPS of $1.35. Check the earnings calendar to see all companies reporting this week.
Henry Schein (HSIC) — frequently asked questions
When does Henry Schein (HSIC) report earnings next?
Henry Schein is expected to report earnings on November 3, 2026 before market open. Analysts estimate EPS of $1.35.
What is Henry Schein's market cap?
Henry Schein (HSIC) has a market capitalization of $10.08B.
What is HSIC's P/E ratio?
Henry Schein trades at a price-to-earnings ratio of 16.7, with trailing twelve-month EPS of $5.31.
How fast is Henry Schein growing?
Henry Schein's revenue grew +6.5% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)